ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,766Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 682

$920K Total Retail Price of All Prescriptions

Rank: 125 out of 682

455 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

45% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 10,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,342 521 S3 1 1
LISINOPRIL 618 420 2 2
OMEPRAZOLE 484 247 3 5
SIMVASTATIN 462 289 4 4
LEVOTHYROXINE SODIUM 459 353 5 3
FUROSEMIDE 410 323 6 7
GABAPENTIN 398 188 7 9
CARISOPRODOL 368 63 R 8 146
PROMETHAZINE HCL 330 132 R 9 54
METFORMIN HCL 318 201 10 8
ZOLPIDEM TARTRATE 289 129 11 21
POTASSIUM CHLORIDE 286 206 12 14
NEXIUM 268 203 13 19
LOSARTAN POTASSIUM 258 183 14 20
AMLODIPINE BESYLATE 241 126 15 6
ISOSORBIDE MONONITRATE ER 220 195 16 31
CLOPIDOGREL 212 169 17 25
CARVEDILOL 195 135 18 23
METOPROLOL SUCCINATE 191 160 19 16
RANITIDINE HCL 190 139 20 28
HYDROCHLOROTHIAZIDE 184 119 21 12
METOPROLOL TARTRATE 165 121 22 10
PLAVIX 160 122 23 35
PROAIR HFA 156 73 24 45
TAMSULOSIN HCL 130 83 25 33
AMITRIPTYLINE HCL 130 42 R 25 50
LANTUS 128 90 27 55
ATORVASTATIN CALCIUM 125 102 28 11
CYMBALTA 121 48 29 51
DIGOXIN 120 85 30 46
FLUOXETINE HCL 119 36 31 60
WARFARIN SODIUM 117 87 32 13
DILTIAZEM 24HR CD 112 96 33 123
TRAZODONE HCL 109 59 34 38
PAROXETINE HCL 106 53 35 53
POLYETHYLENE GLYCOL 3350 102 89 36 44
DOXAZOSIN MESYLATE 102 99 36 96
ATENOLOL 98 46 38 18
MIRTAZAPINE 94 33 39 52
RANEXA 91 91 40 223
CELEBREX 90 64 41 80
ALLOPURINOL 86 67 42 32
DILTIAZEM 24HR ER 86 41 42 162
DONEPEZIL HCL 85 77 44 30
CITALOPRAM HBR 85 34 44 17
LOSARTAN-HYDROCHLOROTHIAZIDE 84 83 46 56
TRAMADOL HCL 79 42 47 26
IBUPROFEN 79 13 47 79
HYDROXYZINE PAMOATE 79 23 R 47 172
ADVAIR DISKUS 78 60 50 47
JANUVIA 78 75 50 62
NYSTATIN 76 74 52 95
CYCLOBENZAPRINE HCL 75 41 R 53 65
PRAVASTATIN SODIUM 75 43 53 15
VENLAFAXINE HCL 71 69 55 225
LANSOPRAZOLE 71 38 55 85
FLUTICASONE PROPIONATE 68 49 57 36
GLYBURIDE 68 55 R 57 72
ABILIFY 67 18 59 179
SPIRONOLACTONE 64 42 60 64
AMIODARONE HCL 64 56 60 170
LYRICA 64 13 60 78
SERTRALINE HCL 64 38 60 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 26 64 34
AZITHROMYCIN 61 41 65 39
DILTIAZEM ER 61 43 65 136
LACTULOSE 59 59 67 100
PANTOPRAZOLE SODIUM 59 38 67 29
ACTOS 59 39 67 151
VENLAFAXINE HCL ER 59 40 67 119
COMBIVENT 58 31 71 105
CRESTOR 56 46 72 22
OXYCODONE-ACETAMINOPHEN 56 0 S2 72 120
CEFUROXIME 56 31 72 164
SPIRIVA 54 32 75 49
DIOVAN HCT 53 41 76 109
OXYCODONE HCL-ACETAMINOPHEN 52 21 S2 77 98
METOCLOPRAMIDE HCL 51 21 78 111
ALPRAZOLAM 51 14 78 90
QUETIAPINE FUMARATE 51 28 78 87
PRADAXA 50 50 81 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.